Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
AstraZeneca's Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
Fierce Biotech
Fri, 12/16/22 - 10:47 am
AstraZeneca
Alexion
PNH
Ultomiris
Soliris
Roche
Apellis
Novartis
Roche wins earlier-than-expected approval for blockbuster Tecentriq in rare soft tissue cancer
Endpoints
Tue, 12/13/22 - 11:50 pm
Roche
Tecentriq
FDA
soft tissue cancer
ASH: Roche records phase 3 rare disease win ahead of Soliris showdown
Fierce Biotech
Mon, 12/12/22 - 10:29 am
ASH 2022
Roche
PNH
crovalimab
AstraZeneca
Soliris
After 16 Years, Roche's Pharma Division Head Decides To Step Down
Yahoo/Benzinga
Mon, 12/12/22 - 10:24 am
Roche
Bill Anderson
ASH: Roche touts Lunsumio's durable efficacy as AbbVie, Regeneron plot lymphoma bispecific battle
Fierce Pharma
Mon, 12/12/22 - 10:21 am
Roche
ASH 2022
AbbVie
Regeneron
lymphoma
Lunsumio
glofitamab
Combo of Roche's Tecentriq and Exelixis' Cabometyx fails another trial, this time in lung cancer
Fierce Pharma
Sun, 12/11/22 - 01:20 pm
Roche
Tecentriq
Exelixis
Cabometyx
clinical trials
non small cell lung cancer
SABCS: AZ writes the 'next chapter' in Enhertu's saga with head-to-head win versus Roche's Kadcyla
Fierce Pharma
Fri, 12/9/22 - 10:54 am
SABCS
AstraZeneca
Enhertu
breast cancer
Daiichi Sankyo
Roche
Kadcyla
Roche, having shared data with regulators, unwraps results of subcutaneous Tecentriq phase 3 trial
Fierce Pharma
Thu, 12/1/22 - 10:55 am
Roche
Tecentriq
clinical trials
non-small cell lung cancer
CTAD 2022 – gantenerumab’s shortcomings keep amyloid hypothesis alive
EP Vantage
Thu, 12/1/22 - 10:28 am
Roche
clinical trials
CTAD
Alzheimer's disease
gantenerumab
Go or no go? Mirati heads to the FDA
EP Vantage
Wed, 11/30/22 - 10:34 am
FDA
Mirati Therapeutics
Gilead Sciences
Coherus Biosciences
Roche
Biogen
TG Therapeutics
Ipsen
Novartis
BeiGene
Cytokinetics
Roche Withdraws Tecentric for Bladder Cancer Indication
BioSpace
Tue, 11/29/22 - 11:06 am
Roche
Genentech
bladder cancer
metastatic bladder cancer
Tecentriq
FogPharma’s $178M Funding Leads Way as 7 Biotechs Raise Cash for Cancer Drugs
MedCity News
Sun, 11/27/22 - 07:04 pm
FogPharma
funding
cancer
CatalYm
Roche
Opna Bio
Rezo Therapeutics
Despite high demand, Tamiflu drugmaker says it's on track with supply
Beckers Hospital Review
Mon, 11/21/22 - 07:18 pm
Tamiflu
Flu
Roche
AbbVie's Roche-rivaling blood cancer bispecific gets FDA priority review, triggering Genmab payday
Fierce Biotech
Mon, 11/21/22 - 10:12 am
AbbVie
Genmab
FDA
Roche
epcoritamab
bispecific antibodies
relapsed or refractory large B-cell lymphoma
Roche Failure Leaves Industry Reassessing Alzheimer's Space
BioSpace
Wed, 11/16/22 - 10:45 am
Roche
Alzheimer's disease
gantenerumab
Biogen
Cassava Sciences
Eli Lilly
Roche Doubles Down on Jnana's RAPID Platform in $2B Deal (Updated)
BioSpace
Wed, 11/16/22 - 10:13 am
Roche
Jnana Therapeutics
small molecule drugs
drug development
After $250M Roche buyout, a startup plans a second strike with fresh funding
BioPharma Dive
Tue, 11/15/22 - 10:36 am
Bonum Therapeutics
startups
Roche
Good Therapeutics
funding
Trial failures end latest hope for Roche’s Alzheimer’s drug
BioPharma Dive
Mon, 11/14/22 - 10:57 am
Roche
Alzheimer's disease
gantenerumab
clinical trials
As Roche prepares to take a kidney disease drug into PhIII, Ionis fleshes out the data
Endpoints
Mon, 11/7/22 - 05:24 pm
Roche
Ionis Pharmaceuticals
IONIS-FB-LRx
kidney disease
Roche introduces the navify brand for its digital health solutions at HLTH 2022
BioSpace
Fri, 11/4/22 - 11:05 am
Roche
navify
digital health
software
digital pharma
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »